AMORENA TOMPKINS: Open Payments
NPI 1952861874 · BINGHAM FARMS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$477 in 6 payments from 5 companies in 2025. Trend: 2023 $653 · 2024 $1,045 · 2025 $477
Food & beverage: $477
| Company | Payments | Amount |
|---|---|---|
| Intra-Sana Laboratories | 2 | $174 |
| Madrigal Pharmaceuticals | 1 | $107 |
| Otsuka America Pharmaceutical, Inc. | 1 | $69 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $68 |
| Boston Scientific Corporation | 1 | $59 |
Products named: RELTONE 200 MG, REZDIFFRA, REXULTI, JOURNAVX, WATCHMAN FLX.
Industry payments across MI — which companies pay providers there.
